Australia's pharmaceutical benefits scheme is being challenged by lobbying from US industry, writes Patricia Ranald. Giant US pharmaceutical and tobacco corporations are setting the agenda at negotiations over the Trans-Pacific Partnership free trade agreement (TPPA) between Australia, the US, New ...

More »